{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:33:22Z","timestamp":1790400802088,"version":"4.1.0"},"reference-count":88,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,20]]},"DOI":"10.4103\/0366-6999.231512","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T06:41:19Z","timestamp":1525070479000},"page":"1232-1239","source":"Crossref","is-referenced-by-count":41,"title":["Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations"],"prefix":"10.1097","volume":"131","author":[{"given":"Xian-Zhe","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Zhi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Xian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Qing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210129","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ijc.24290","article-title":"Recent patterns in gastric cancer: A global overview","volume":"125","author":"Bertuccio","year":"2009","journal-title":"Int J Cancer"},{"key":"R2-15-20210129","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/CEJ.0b013e328364f2b6","article-title":"Model-based patterns in stomach cancer mortality worldwide","volume":"23","author":"Peleteiro","year":"2014","journal-title":"Eur J Cancer Prev"},{"key":"R3-15-20210129","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"R4-15-20210129","first-page":"3554","article-title":"A human model of gastric carcinogenesis","volume":"48","author":"Correa","year":"1988","journal-title":"Cancer Res"},{"key":"R5-15-20210129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3164\/jcbn.08-254","article-title":"The expression of murine double minute 2 (MDM2) on Helicobacter pylori-infected intestinal metaplasia and gastric cancer","volume":"44","author":"Nakajima","year":"2009","journal-title":"J Clin Biochem Nutr"},{"key":"R6-15-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification","volume":"64","author":"Lauren","year":"1965","journal-title":"Acta Pathol Microbiol Scand"},{"key":"R7-15-20210129","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.7314\/APJCP.2012.13.6.2481","article-title":"Sodium intake, salt taste and gastric cancer risk according to Helicobacter pylori infection, smoking, histological type and tumor site in China","volume":"13","author":"Zhong","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"R8-15-20210129","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02990095","article-title":"Long-term Helicobacter pylori infection and the development of atrophic gastritis and gastric cancer in Japan","volume":"37","author":"Takahashi","year":"2002","journal-title":"J Gastroenterol"},{"key":"R9-15-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00365521.2016.1183225","article-title":"Risk of gastric cancer in Helicobacter pylori infection in a 15-year follow-up","volume":"51","author":"Vohlonen","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"R10-15-20210129","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/gut.47.5.618","article-title":"Natural history of early gastric cancer: A non-concurrent, long term, follow up study","volume":"47","author":"Tsukuma","year":"2000","journal-title":"Gut"},{"key":"R11-15-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.suronc.2013.05.002","article-title":"Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy","volume":"22","author":"Lu","year":"2013","journal-title":"Surg Oncol"},{"key":"R12-15-20210129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10120-006-0399-y","article-title":"Detection of early gastric cancer: Misunderstanding the role of mass screening","volume":"9","author":"Suzuki","year":"2006","journal-title":"Gastric Cancer"},{"key":"R13-15-20210129","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ijc.2910380608","article-title":"Evaluation of a mass screening program for stomach cancer with a case-control study design","volume":"38","author":"Oshima","year":"1986","journal-title":"Int J Cancer"},{"key":"R14-15-20210129","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ijc.2910600106","article-title":"The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan: A population-based case-control study","volume":"60","author":"Fukao","year":"1995","journal-title":"Int J Cancer"},{"key":"R15-15-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jjco\/hyn017","article-title":"The Japanese guidelines for gastric cancer screening","volume":"38","author":"Hamashima","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"R16-15-20210129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10120-006-0397-0","article-title":"Gastric cancer screening using the serum pepsinogen test method","volume":"9","author":"Miki","year":"2006","journal-title":"Gastric Cancer"},{"key":"R18-15-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1470-2045(08)70072-X","article-title":"Screening for gastric cancer in Asia: Current evidence and practice","volume":"9","author":"Leung","year":"2008","journal-title":"Lancet Oncol"},{"key":"R19-15-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13277-016-5129-4","article-title":"Noninvasive detection of gastric cancer","volume":"37","author":"Wan","year":"2016","journal-title":"Tumour Biol"},{"key":"R20-15-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000441742","article-title":"Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels \u2013 The ABC method","volume":"93","author":"Yamaguchi","year":"2016","journal-title":"Digestion"},{"key":"R23-15-20210129","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1523-5378.2010.00799.x","article-title":"Strategy for eliminating gastric cancer in Japan","volume":"15","author":"Asaka","year":"2010","journal-title":"Helicobacter"},{"key":"R25-15-20210129","doi-asserted-by":"crossref","first-page":"e0170942","DOI":"10.1371\/journal.pone.0170942","article-title":"Distinct clinicopathological features and prognosis of Helicobacter pylori negative gastric cancer","volume":"12","author":"Tsai","year":"2017","journal-title":"PLoS One"},{"key":"R26-15-20210129","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1349-7006.2007.00478.x","article-title":"Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: Incidence and pathological characteristics","volume":"98","author":"Kato","year":"2007","journal-title":"Cancer Sci"},{"key":"R27-15-20210129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1523-5378.2011.00889.x","article-title":"Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese","volume":"16","author":"Matsuo","year":"2011","journal-title":"Helicobacter"},{"key":"R28-15-20210129","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1523-5378.2011.00859.x","article-title":"Helicobacter pylori-negative gastric cancer in South Korea: Incidence and clinicopathologic characteristics","volume":"16","author":"Yoon","year":"2011","journal-title":"Helicobacter"},{"key":"R29-15-20210129","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/den.12471","article-title":"Helicobacter pylori-negative gastric cancer: Characteristics and endoscopic findings","volume":"27","author":"Yamamoto","year":"2015","journal-title":"Dig Endosc"},{"key":"R30-15-20210129","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1440-1746.2009.06188.x","article-title":"Epidemiology of Helicobacter pylori infection and gastric cancer in Asia","volume":"25","author":"Fock","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R31-15-20210129","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0046-8177(92)90132-M","article-title":"Pathologic changes of gastric mucosa colonized by Helicobacter pylori","volume":"23","author":"Hui","year":"1992","journal-title":"Hum Pathol"},{"key":"R32-15-20210129","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00004836-199712000-00007","article-title":"Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia","volume":"25","author":"Hsu","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"R33-15-20210129","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4049\/jimmunol.1202088","article-title":"Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8\/A9 proinflammatory proteins","volume":"190","author":"Wang","year":"2013","journal-title":"J Immunol"},{"key":"R34-15-20210129","first-page":"293","article-title":"Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection","volume":"50","author":"Koizumi","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"R35-15-20210129","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/phrs.1999.0586","article-title":"Pepsinogens: Physiology, pharmacology pathophysiology and exercise","volume":"41","author":"Gritti","year":"2000","journal-title":"Pharmacol Res"},{"key":"R36-15-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0016-5085(19)33596-6","article-title":"Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence","volume":"61","author":"Samloff","year":"1971","journal-title":"Gastroenterology"},{"key":"R37-15-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0016-5085(19)33138-5","article-title":"Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence","volume":"65","author":"Samloff","year":"1973","journal-title":"Gastroenterology"},{"key":"R38-15-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0009-8981(82)90095-X","article-title":"Radioimmunoassay of group II pepsinogen in human serum","volume":"122","author":"Ichinose","year":"1982","journal-title":"Clin Chim Acta"},{"key":"R39-15-20210129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0009-8981(82)90034-1","article-title":"Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders","volume":"126","author":"Ichinose","year":"1982","journal-title":"Clin Chim Acta"},{"key":"R40-15-20210129","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0016-5085(82)90176-7","article-title":"Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia","volume":"83","author":"Samloff","year":"1982","journal-title":"Gastroenterology"},{"key":"R41-15-20210129","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.7314\/APJCP.2013.14.6.3931","article-title":"Serum gastrin and the pepsinogen I\/II ratio as markers for diagnosis of premalignant gastric lesions","volume":"14","author":"Shafaghi","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"R42-15-20210129","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.3748\/wjg.v18.i48.7357","article-title":"Serum pepsinogen II is a better diagnostic marker in gastric cancer","volume":"18","author":"Cao","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R43-15-20210129","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.7314\/APJCP.2014.15.17.7433","article-title":"Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in Northern Iran","volume":"15","author":"Nejadi-Kelarijani","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R44-15-20210129","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/jgh.12987","article-title":"Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels","volume":"30","author":"Kitamura","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"R45-15-20210129","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2183\/pjab.87.405","article-title":"Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels \u2013 \u201cABC method\u201d","volume":"87","author":"Miki","year":"2011","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"R46-15-20210129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0002-9270(02)04611-7","article-title":"Usefulness of gastric cancer screening using the serum pepsinogen test method","volume":"97","author":"Miki","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R47-15-20210129","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1023\/A:1018833819860","article-title":"Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan","volume":"42","author":"Watanabe","year":"1997","journal-title":"Dig Dis Sci"},{"key":"R48-15-20210129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s10120-015-0473-4","article-title":"The new modified ABCD method for gastric neoplasm screening","volume":"19","author":"Park","year":"2016","journal-title":"Gastric Cancer"},{"key":"R49-15-20210129","first-page":"1790","article-title":"Gastric cancer screening using ABC classification","volume":"70","author":"Inoue","year":"2012","journal-title":"Nihon Rinsho"},{"key":"R50-15-20210129","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gut.2004.055400","article-title":"Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: A prospective endoscopic cohort study","volume":"54","author":"Watabe","year":"2005","journal-title":"Gut"},{"key":"R51-15-20210129","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.3748\/wjg.v17.i43.4793","article-title":"Analysis of ABC (D) stratification for screening patients with gastric cancer","volume":"17","author":"Kudo","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R52-15-20210129","doi-asserted-by":"crossref","first-page":"156719","DOI":"10.1155\/2015\/156719","article-title":"Helicobacter pylori antibody titer and gastric cancer screening","volume":"2015","author":"Kishikawa","year":"2015","journal-title":"Dis Markers"},{"key":"R53-15-20210129","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2188\/jea.JE20150258","article-title":"Combination of Helicobacter pylori antibody and serum pepsinogen as a good predictive tool of gastric cancer incidence: 20-year prospective data from the Hisayama study","volume":"26","author":"Ikeda","year":"2016","journal-title":"J Epidemiol"},{"key":"R54-15-20210129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1440-1746.2011.06961.x","article-title":"Future candidates for indications of Helicobacter pylori eradication: Do the indications need to be revised?","volume":"27","author":"Lee","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R55-15-20210129","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3748\/wjg.v22.i3.1311","article-title":"Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance","volume":"22","author":"Liu","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R56-15-20210129","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1053\/j.gastro.2009.07.060","article-title":"Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease","volume":"137","author":"Wu","year":"2009","journal-title":"Gastroenterology"},{"key":"R57-15-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00535-006-1924-9","article-title":"Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases","volume":"42","author":"Take","year":"2007","journal-title":"J Gastroenterol"},{"key":"R58-15-20210129","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3904\/kjim.2016.166","article-title":"Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection","volume":"31","author":"Lee","year":"2016","journal-title":"Korean J Intern Med"},{"key":"R59-15-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000446771","article-title":"Actual status of involvement of Helicobacter pylori infection that developed gastric cancer from group A of ABC (D) stratification \u2013 Study of early gastric cancer cases that underwent endoscopic submucosal dissection","volume":"94","author":"Miura","year":"2016","journal-title":"Digestion"},{"key":"R60-15-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000335260","article-title":"Gastric cancer development after Helicobacter pylori eradication therapy: A new form of gastric neoplasia","volume":"85","author":"Matsuo","year":"2012","journal-title":"Digestion"},{"key":"R61-15-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12101","article-title":"Advanced method for evaluation of gastric cancer risk by serum markers: Determination of true low-risk subjects for gastric neoplasm","volume":"19","author":"Boda","year":"2014","journal-title":"Helicobacter"},{"key":"R62-15-20210129","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00535-010-0347-9","article-title":"The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori","volume":"46","author":"Take","year":"2011","journal-title":"J Gastroenterol"},{"key":"R63-15-20210129","doi-asserted-by":"crossref","first-page":"10553","DOI":"10.3748\/wjg.v21.i37.10553","article-title":"Endoscopic surveillance of gastric cancers after Helicobacter pylori eradication","volume":"21","author":"Kobayashi","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R64-15-20210129","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/ijc.27514","article-title":"Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis","volume":"131","author":"Watanabe","year":"2012","journal-title":"Int J Cancer"},{"key":"R65-15-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R66-15-20210129","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ijc.28999","article-title":"Global burden of gastric cancer attributable to Helicobacter pylori","volume":"136","author":"Plummer","year":"2015","journal-title":"Int J Cancer"},{"key":"R67-15-20210129","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5009\/gnl17063","article-title":"Associations among gastric juice pH, atrophic gastritis, intestinal metaplasia and Helicobacter pylori infection","volume":"12","author":"Sung","year":"2018","journal-title":"Gut Liver"},{"key":"R68-15-20210129","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3109\/00365521.2013.838994","article-title":"Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer","volume":"48","author":"Kodama","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"R69-15-20210129","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/1940-6207.CAPR-12-0428","article-title":"How long will it take to reduce gastric cancer incidence by eradicating Helicobacter pylori infection?","volume":"6","author":"Osborn","year":"2013","journal-title":"Cancer Prev Res (Phila"},{"key":"R70-15-20210129","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.gtc.2015.05.009","article-title":"Gastric cancer risk in patients with Helicobacter pylori infection and following its eradication","volume":"44","author":"Rugge","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"R71-15-20210129","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.gtc.2015.05.010","article-title":"Helicobacter pylori eradication to eliminate gastric cancer: The Japanese strategy","volume":"44","author":"Asaka","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"R72-15-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1523-5378.2009.00681.x","article-title":"Clinical significance of IgG antibody titer against Helicobacter pylori","volume":"14","author":"Tatemichi","year":"2009","journal-title":"Helicobacter"},{"key":"R73-15-20210129","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ijc.28470","article-title":"Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer","volume":"134","author":"Yoshida","year":"2014","journal-title":"Int J Cancer"},{"key":"R74-15-20210129","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10120-015-0462-7","article-title":"Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: Evidence from a meta-analysis","volume":"19","author":"Chen","year":"2016","journal-title":"Gastric Cancer"},{"key":"R75-15-20210129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","article-title":"Helicobacter pylori-induced gastric inflammation and gastric cancer","volume":"345","author":"Wang","year":"2014","journal-title":"Cancer Lett"},{"key":"R76-15-20210129","first-page":"151","article-title":"Helicobacter pylori infection, gastric cancer and gastropanel","volume":"54","author":"Loor","year":"2016","journal-title":"Rom J Intern Med"},{"key":"R77-15-20210129","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1007\/s10620-010-1154-0","article-title":"Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis","volume":"55","author":"Mizuno","year":"2010","journal-title":"Dig Dis Sci"},{"key":"R78-15-20210129","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s10096-011-1543-0","article-title":"Serum pepsinogen and Helicobacter pylori infection \u2013 A Japanese population study","volume":"31","author":"Toyoda","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R79-15-20210129","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.amjms.2016.08.005","article-title":"Serum pepsinogen levels are correlated with age, sex and the level of Helicobacter pylori infection in healthy individuals","volume":"352","author":"Huang","year":"2016","journal-title":"Am J Med Sci"},{"key":"R80-15-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1443-9573.2007.00271.x","article-title":"Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies","volume":"8","author":"Cao","year":"2007","journal-title":"J Dig Dis"},{"key":"R81-15-20210129","first-page":"172","article-title":"Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis","volume":"17","author":"B\u00f6l\u00fckba\u015f","year":"2006","journal-title":"Turk J Gastroenterol"},{"key":"R82-15-20210129","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/gut.33.4.452","article-title":"Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors","volume":"33","author":"Veenendaal","year":"1992","journal-title":"Gut"},{"key":"R83-15-20210129","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.3748\/wjg.v20.i18.5461","article-title":"Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development","volume":"20","author":"Watari","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R84-15-20210129","doi-asserted-by":"crossref","first-page":"S870","DOI":"10.1371\/journal.pone.0163700","article-title":"Apossible link between gastric mucosal atrophy and gastric cancer after Helicobacter pylori eradication","volume":"11","author":"Tahara","year":"2016","journal-title":"PLoS One"},{"key":"R85-15-20210129","first-page":"59","article-title":"Croatian guidelines for gastric cancer prevention by eradication of Helicobacter pylori infection","volume":"136","author":"Katici\u0107","year":"2014","journal-title":"Lijec Vjesn"},{"key":"R86-15-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00428-011-1177-8","article-title":"Management of precancerous conditions and lesions in the stomach (MAPS): Guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)","volume":"460","author":"Dinis-Ribeiro","year":"2012","journal-title":"Virchows Arch"},{"key":"R87-15-20210129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.medici.2014.05.001","article-title":"Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy","volume":"50","author":"Leja","year":"2014","journal-title":"Medicina (Kaunas"},{"key":"R88-15-20210129","doi-asserted-by":"crossref","first-page":"e0183980","DOI":"10.1371\/journal.pone.0183980","article-title":"Asignificant increase in the pepsinogen I\/II ratio is a reliable biomarker for successful Helicobacter pylori eradication","volume":"12","author":"Osumi","year":"2017","journal-title":"PLoS One"},{"key":"R89-15-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/1751-2980.12144","article-title":"Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm","volume":"15","author":"Choi","year":"2014","journal-title":"J Dig Dis"},{"key":"R90-15-20210129","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000477239","article-title":"Serological evaluation of gastric cancer risk based on pepsinogen and Helicobacter pylori antibody: Relationship to endoscopic findings","volume":"95","author":"Kotachi","year":"2017","journal-title":"Digestion"},{"key":"R91-15-20210129","first-page":"6765","article-title":"Predictors of gastric neoplasia in cases negative for Helicobacter pylor i antibody and with normal pepsinogen","volume":"35","author":"Kishikawa","year":"2015","journal-title":"Anticancer Res"},{"key":"R92-15-20210129","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1440-1746.2012.07285.x","article-title":"Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori","volume":"28","author":"Haneda","year":"2013","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.231512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:47:25Z","timestamp":1623959245000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201805200-00015"}},"subtitle":["ABC Method for Gastric Cancer Screening"],"short-title":[],"issued":{"date-parts":[[2018,5,20]]},"references-count":88,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.231512","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,20]]}}}